0000000000853442

AUTHOR

Lanzetta Gaetano

showing 3 related works from this author

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey.

2013

BackgroundBone metastasis represents an increasing clinical problem in advanced renal cell carcinoma (RCC) as disease-related survival improves. There are few data on the natural history of bone disease in RCC.Patients and methodsData on clinicopathology, survival, skeletal-related events (SREs), and bone-directed therapies for 398 deceased RCC patients (286 male, 112 female) with evidence of bone metastasis were statistically analyzed.ResultsMedian time to bone metastasis was 25 months for patients without bone metastasis at diagnosis. Median time to diagnosis of bone metastasis by MSKCC risk was 24 months for good, 5 months for intermediate, and 0 months for poor risk. Median number of SR…

OncologyMaleAnatomy and PhysiologyBone diseaseEpidemiologySettore MED/06 - Oncologia Medicamedicine.medical_treatmentMetastasisMetastasisbone metastasesRenal cell carcinomaBasic Cancer ResearchMedicineMusculoskeletal SystemMultidisciplinaryDiphosphonatesrenal cell carcinoma bone metastasis zoledronic acidQRBone metastasisKidney NeoplasmsOncologyItalyObservational StudiesDisease ProgressionMedicineFemaleCancer Epidemiologymedicine.drugResearch Articlemedicine.medical_specialtyClinical Research DesignSciencerenal cancerBone NeoplasmsInternal medicineHumansBonerenal cancer; bone metastasesRetrospective Studiesbusiness.industryRenal Cell CarcinomaCancerCancers and NeoplasmsBone fracturemedicine.diseaseSurgeryRadiation therapyGenitourinary Tract TumorsZoledronic acidbusiness
researchProduct

Personalized goal for insomnia and clinical response in advanced cancer patients.

2019

Aim: The aim of this study was to assess the Personalized Insomnia Intensity Goal (PIIG), the achievement of Personalized Goal Response (PGR), and Patient Global Impression (PGI) after a comprehensive symptom management. Patients and methods: Advanced cancer patients admitted to palliative care units rated pain and symptoms intensity and their PIIG by using the Edmonton Symptom Assessment Score (ESAS) (T0). In patients with significant levels of insomnia, the achievement of target expected (PIIG) was measured (patient goal response, PIGR), as well the patient global impression (PGI), by the minimal clinically important difference (MCID), after a comprehensive symptom management (T7). Result…

AdultMalemedicine.medical_specialtyPalliative careInsomniaDecision MakingPainSymptom assessmentGlobal impression of change03 medical and health sciences0302 clinical medicineInternal medicineAdvanced cancerNeoplasmsSleep Initiation and Maintenance DisordersInsomniamedicineHumansPain ManagementIn patient030212 general & internal medicineAgedAged 80 and overSymptom managementbusiness.industryMinimal clinically important differencePalliative CareMiddle AgedAdvanced cancerIntensity (physics)HospitalizationOncology030220 oncology & carcinogenesisPersonalized symptom goalFemalemedicine.symptomSymptom AssessmentbusinessGoalsSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

Personalized Pain Goals and Responses in Advanced Cancer Patients

2020

Abstract Objective To assess the personalized pain intensity goal (PPIG), the achievement of a personalized pain goal response (PPGR), and patients' global impression (PGI) in advanced cancer patients after a comprehensive pain and symptom management. Design Prospective, longitudinal Setting Acute pain relief and palliative/supportive care. Subjects 689 advanced cancer patients. Methods Measurement of Edmonton Symptom Assessment Score (ESAS) and personalized pain intensity goal (PPIG) at admission (T0). After a week (T7) personalized pain goal response (PPGR) and patients' global impression (PGI) were evaluated. Results The mean PPIG was 1.33 (SD 1.59). A mean decrease in pain intensity of …

AdultMalemedicine.medical_specialtyPalliative careAdolescentSymptom assessmentYoung Adult03 medical and health sciences0302 clinical medicineHumansPain ManagementMedicine030212 general & internal medicinePrecision MedicineAcute painAgedPain MeasurementAged 80 and overbusiness.industrySymptom managementMinimal clinically important differenceClinical ResponseGeneral MedicineCancer PainMiddle AgedAdvanced cancerIntensity (physics)Anesthesiology and Pain Medicine030220 oncology & carcinogenesisPhysical therapyFemalePain IntensityNeurology (clinical)businessCancer painGoals
researchProduct